{"id":"NCT01555463","sponsor":"LEO Pharma","briefTitle":"Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea","officialTitle":"A Randomized, Double-blind, Vehicle-controlled, Multicenter, Parallel-group Clinical Trial to Assess the Safety and Efficacy of Azelaic Acid Foam, 15% Topically Applied Twice Daily for 12 Weeks in Subjects With Papulopustular Rosacea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-09","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2012-03-15","resultsPosted":"2015-01-27","lastUpdate":"2023-06-09"},"enrollment":961,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Papulopustular Rosacea"],"interventions":[{"type":"DRUG","name":"Azelaic acid foam, 15% (BAY39-6251)","otherNames":[]},{"type":"DRUG","name":"Vehicle foam","otherNames":[]}],"arms":[{"label":"Azelaic acid foam, 15% (BAY39-6251)","type":"EXPERIMENTAL"},{"label":"Vehicle foam","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and efficacy of azelaic acid (AzA) foam, 15% topically applied twice daily for 12 weeks in subjects with papulopustular rosacea compared to its vehicle.","primaryOutcome":{"measure":"Percentage of Participants With Investigator's Global Assessment (IGA) Based Therapeutic Success at End of Treatment (LOCF: Last Observation Carried Forward)","timeFrame":"At end of treatment (LOCF), up to 12 weeks","effectByArm":[{"arm":"Azelaic Acid Foam, 15% (BAY39-6251)","deltaMin":32.1,"sd":null},{"arm":"Vehicle Foam","deltaMin":23.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":49,"countries":["United States"]},"refs":{"pmids":["26244354"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":483},"commonTop":["Nasopharyngitis","Headache","Application site pain","Upper respiratory tract infection","Application site pruritus"]}}